A toxin produced by bacteria as a defence mechanism causes mutations in target bacteria that could help them survive, according to a study published today in eLife.
The finding suggests that competitive encounters between bacterial cells could have profound consequences on the evolution of bacterial populations.
When bacterial cells come into contact, they often produce toxins as a defence mechanism. Although it is known that the bacteria producing these toxins have a competitive advantage, exactly how the toxins affect the recipient cells is less clear.
“Undergoing intoxication is not always detrimental for cells – there are scenarios in which encountering a toxin could provide a benefit, such as generating antibiotic resistance,” explains lead author Marcos de Moraes, Postdoctoral Scholar at the University of Washington School of Medicine, Seattle, US. “We wanted to study the effects of a toxin that alters DNA beyond that of cell death and see how it impacts the surviving recipient cells it targets.”
The team began by studying a toxin called DddA (double-stranded deaminase A), found in a bacterial species called Burkholderia cenocepacia. DddA removes chemical groups called amines from DNA, causing a specific change in the genetic code.
To understand how DddA kills bacterial cells, the team looked at how a large dose of the toxin affects chromosomes in Escherichia coli (E. coli). They found that DddA caused rapid disintegration of chromosomes and the breakdown of DNA replication. Additionally, when they sequenced the DNA before it had disintegrated, they found widespread mutations consistent with the types of chemical changes DddA can make.
Despite this ability to cause such damage, the team was surprised to find that DddA failed to kill the E. coli cells when it was delivered at natural levels by the producing bacterium. This led them to test whether DddA was naturally toxic against other bacterial species. They identified several species that were susceptible to DddA when delivered by Burkholderia cenocepacia, and set out to determine the mechanism. As they expected, they found the same accumulation of mutations and chromosome damage that occurred when a large dose of DddA was given to E. coli.
However, given that DddA failed to kill E. coli when delivered by the natural route, the team was keen to test whether sub-lethal exposure to DddA caused mutations that provide a benefit. They found that E. coli grown in competition with DddA-producing Burkholderia cenocepacia cells for one hour had a ten-fold increase in antibiotic-resistant cells compared to E. coli that was not exposed to DddA. When they sequenced the DNA of the resistant E. coli cells, they saw that resistance had been caused by the hallmark mutations that DddA generates.
They next looked at other bacterial cells that were resistant or sensitive to death when exposed to DddA delivered by Burkholderia cenocepacia. Among additional resistant organisms, the human pathogens Klebsiella pneumoniae and enterohemorrhagic E. coli had higher numbers of antibiotic-resistant cells when in contact with DddA, and had the hallmark mutation signatures of DddA damage. By contrast, in cells sensitive to killing by DddA, there was no increased level of mutations, and only 15% of antibiotic-resistant clones had mutation patterns similar to those caused by DddA. This suggests that mutations may be a rare outcome of DddA toxicity in sensitive species that survive intoxication, but additional study will be needed to support this association.
The team went on to characterise additional classes of DddA-like toxins and identified a related toxin from the plant pathogen Pseudomonas syringae. Although this toxin still makes the same pattern of chemical changes to DNA, it was found to act on single-stranded DNA – so the researchers called it single-strand DNA deaminase (SsdA). Structural analysis of SsdA1 confirmed its relationship within the same family of toxins as DddA, although it contains remarkable differences, prompting questions about its evolutionary origins.
“This study reveals that interbacterial toxins may be relevant contributors to bacterial genetic diversity in natural microbial communities, giving cells that survive the toxin a leg up in the rare – but critical – instances where those mutations provide a benefit,” concludes senior author Joseph Mougous, Professor of Microbiology at the University of Washington, and Howard Hughes Medical Institute Investigator. “This could be clinically relevant as well, where bacteria that possess these toxins are present and resistance to certain antibiotics requires a succession of mutations.”
##
This study will be published as part of eLife's Special Issue on evolutionary medicine. For more information, visit https://elifesciences.org/inside-elife/bb34a238/special-issue-call-for-papers-in-evolutionary-medicine.
Media contacts
Emily Packer
eLife
e.packer@elifesciences.org
+441223855373
About
eLife is a non-profit organisation created by funders and led by researchers. Our mission is to accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours. We aim to publish work of the highest standards and importance in all areas of biology and medicine, including Genetics and Genomics and Microbiology and Infectious Disease, while exploring creative new ways to improve how research is assessed and published. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.
To read the latest Genetics and Genomics research published in eLife, visit https://elifesciences.org/subjects/genetics-genomics.
And for the latest in Microbiology and Infectious Disease, see https://elifesciences.org/subjects/microbiology-infectious-disease.
